Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (62)	10/11/2002 10:59:06 AM
From: Jibacoa	Respond to of 3722

NERX Is down 15.79% today on low volume, erasing yesterday's gain.<g> It is selling at 0.38 of book and seems headed to retest its October 1 L at $0.24 in spite of reported insider and institutional buying. It was downgraded by Raymond James last month, the FDA has requested that it puts its PreTarget programs on hold, it has cut down 30% of its work force and the NAZ has given it a warning of listing non-compliance.<g> siliconinvestor.com siliconinvestor.com siliconinvestor.com Bernard